Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Common financial budgeting issues can disrupt your financial goals. Learn to identify and address these challenges for better budgeting.
19,311 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
MicroStrategy is pursuing a sizable buyback of zero-coupon convertible notes, a move some critics say reveals liquidi...
A leading analyst questions SpaceX's IPO math and governance, casting doubt on the deal's potential for investors. He...
QuantumForge, a cloud platform company, announced 1,000 layoffs as AI capabilities evolve and currency headwinds bite...
A Deloitte-recognized fast-growing software company launches a phone-scrolling earnings program, sending shares aroun...
The U.S. Treasury reaffirmed that no deals or guarantees with Iran are allowed for safe passage through the Strait of...
A routine retirement withdrawal can trigger unexpected taxes as Social Security becomes taxable. This analysis explai...
A high-stakes exit valued at about $5.5 million and a difficult first quarter have investors re-evaluating risk in bi...
ICE launches an Encompass-integrated Fraud Monitor, centralizing fraud risk signals and property data. Early pilots i...
Wendy's 2026 earnings kickoff for Q1 sheds light on growth drivers, pricing power, and franchise dynamics. This guide...
Los Angeles County registered the largest population decline among U.S. counties last year, a trend shaping budgets a...
Virgin Galactic’s stock having its worst day after a debt-paydown plan triggered dilution fears, snapping a seven-day...